Start for free
Start for free
SC

SilverArc Capital

North America, Massachusetts, United States, Boston

Description

SilverArc Capital is an investment firm.

Investor Profile

SilverArc Capital has made 8 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (63%)
  • Series A (25%)
  • Series C (13%)

Country Focus

  • United States (63%)
  • Germany (13%)
  • Israel (13%)
  • Canada (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Agriculture
  • Genetics
  • Artificial Intelligence (Ai)
  • Enterprise Software
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SilverArc Capital frequently co-invest with?

EcoR1 Capital
EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 2
Nantahala Capital Management
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 3
Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 2
Samsara BioCapital
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 2
6C
683 CAPITAL
North America, New York, United States, New York
Co-Investments: 1
Dellora Investments
Dellora Investments
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Octagon Capital Advisors
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 2
Rock Springs Capital
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Armistice Capital
Armistice Capital
North America, New York, United States, New York
Co-Investments: 3
Walleye Capital
Walleye Capital
North America, Minnesota, United States, Plymouth
Co-Investments: 2

Which angels does SilverArc Capital often collaborate with?

JK
Jon Karlen
North America, Massachusetts, United States, Boston
Shared Deals: 1
PS
Pravin Soni
North America, California, United States, Sunnyvale
Shared Deals: 1
BP
Brad Porter
North America, Washington, United States, Auburn
Shared Deals: 1
AK
Amar Kendale
North America, California, United States, Mountain View
Shared Deals: 1
SF
Steve Fredette
North America, Massachusetts, United States, Boston
Shared Deals: 1
SJ
Sachin Jain
North America, California, United States, Los Angeles
Shared Deals: 1
EJ
Eric Just
North America, Utah, United States, Salt Lake City
Shared Deals: 1
AB
Andrew Bialecki
North America, Massachusetts, United States, Boston
Shared Deals: 1
GS
Gaurav Singal
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by SilverArc Capital?

Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series CMay 9, 2024
Amount Raised: $85,000,000
Unicycive Therapeutics

Los Altos, California, United States

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

BiotechnologyHealth CareHealth DiagnosticsMedical
Post Ipo EquityMar 14, 2024
Amount Raised: $50,000,000
Manifold

Newton, Massachusetts, United States

Manifold is an AI-powered clinical research platform.

Artificial Intelligence (AI)Enterprise SoftwareHealth CareLife ScienceSoftware
Series ANov 14, 2023
Amount Raised: $15,000,000
Gossamer Bio

San Diego, California, United States

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 20, 2023
Amount Raised: $212,000,000
Evogene

Rehovot, HaMerkaz, Israel

Evogene is a biotechnology company developing novel products for life science markets through the use of a unique CPB platform.

AgricultureBiotechnologyGenetics
Post Ipo EquityJul 17, 2023
Amount Raised: $8,500,000
Congruence Therapeutics

Montréal, Quebec, Canada

Congruence Therapeutics operates as a biotechnology company.

BiotechnologyMedical
Series AMar 6, 2023
Amount Raised: $15,000,000
Karyopharm Therapeutics

Newton, Massachusetts, United States

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

Health CareMedicalPharmaceutical
Post Ipo EquityDec 5, 2022
Amount Raised: $165,000,000
immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Post Ipo EquityOct 10, 2022
Amount Raised: $110,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator